Status:
COMPLETED
Mother-caregivers of Children With Duchenne Muscular Dystrophy
Lead Sponsor:
Monica Levy Andersen
Conditions:
Other Diseases or Conditions
Eligibility:
FEMALE
25-65 years
Phase:
NA
Brief Summary
The incidence of Duchenne Muscular Dystrophy (DMD) is approximately 1 in 3.500 male newborns. During its progression there is loss of mobility, swallowing difficulties and a significant reduction in r...
Detailed Description
The Duchenne Muscular Dystrophy (DMD) is a neuromuscular disease characterized by genetic alteration, whose consequence is the progression of muscle degeneration. The mother-caregiver dedicates hersel...
Eligibility Criteria
Inclusion
- Mothers-caregivers of children and adolescents with DMD
- Mothers of children and adolescents without any neuromuscular disease and that does not have any chronic disease (bronchiolitis obliterates, cystic fibrosis, a genetic syndrome)
Exclusion
- Volunteers with low levels of education (voluntary functional illiterate) that prevents the questionnaires and understanding of the guidelines made
- Working mothers of nocturnal period
Key Trial Info
Start Date :
August 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01921374
Start Date
August 1 2013
End Date
July 1 2014
Last Update
February 3 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Federal of São Paulo
São Paulo, São Paulo, Brazil, 04024001